Reaction

Food Intolerance reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,606 reports · 109 co-occurring drugs

As of the last recalculation, Food Intolerance appears in 3,606 FAERS reports alongside 109 co-occurring drug terms. The strongest observed disproportionality signal is AVAPRITINIB (PRR 14.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Avapritinib	30	14.4	14.4
Ciprofolxacin	157	13.2	13.2
Ciprofloxacin Tablets	157	13.2	13.2
Ciprofloxacin	180	11.9	11.9
Ciprofloxacin Hydrochloride	187	11.6	11.7
Azathioprine	135	9.1	9.2
Sulfasalazine	119	9.0	9.1
Pancrelipase	59	9.0	9.0
Botulinum Toxin Type A	18	8.4	8.4
Teduglutide	18	7.7	7.8
Ciclesonide	18	7.7	7.7
Levofloxacin	78	7.6	7.6
Levofloxacin In 5% Dextrose	78	7.6	7.6
Octreotide Acetate	38	7.2	7.2
Desoximetasone	23	7.0	7.0
Cetirizine Hydrochloride Allergy	35	6.7	6.7
Cetirizine Hydrochloride Tablets	35	6.7	6.7
Leflunomide	117	6.6	6.6
Ciprofloxacin Hydrochloride And Hydrocortisone	23	6.4	6.4
Nitrofurantoin	18	6.3	6.3
Nitrofurantoin (Monohydrate/Macrocrystals)	18	6.2	6.3
Drospirenone And Ethinyl Estradiol	47	6.2	6.2
Omalizumab	87	6.0	6.0
Ribociclib	31	5.7	5.7
Hydroxychloroquine	69	5.4	5.4
Pramipexole	14	5.3	5.3
Fexofenadine	15	5.3	5.3
Adalimumab	556	5.2	5.2
Infliximab-Dyyb	26	5.2	5.2
Finasteride	53	5.1	5.1
Hyoscyamine Sulfate	8	5.0	5.0
Dutasteride	7	5.0	5.0
Vedolizumab	71	4.8	4.8
Sulfur	7	4.8	4.8
Rasagiline Mesylate	9	4.7	4.7
Exemestane	17	4.6	4.6
Tranexamic Acid	7	4.5	4.6
Adalimumab-Fkjp	36	4.5	4.5
Hydroxychloroquine Sulfate	70	4.5	4.5
Abatacept	105	4.5	4.5
Dicyclomine Hydrochloride	11	4.5	4.5
Adalimumab-Aaty	36	4.4	4.4
Ceftriaxone Sodium	29	4.4	4.4
Prochlorperazine Maleate	7	4.4	4.4
Thyroid, Porcine	8	4.3	4.3
Mercaptopurine	13	4.3	4.3
Butalbital, Acetaminophen, And Caffeine	8	4.3	4.3
Cetirizine	57	4.3	4.3
Ceftriaxone	24	4.2	4.2
Fulvestrant	23	4.0	4.0
Febuxostat Tablets 40 Mg	7	4.0	4.0
Febuxostat Tablets 80 Mg	7	4.0	4.0
Rizatriptan Benzoate	7	4.0	4.0
Adalimumab-Adaz	36	4.0	4.0
Mesalamine	38	3.9	3.9
Rucaparib	6	3.9	3.9
Terbinafine Hydrochloride	6	3.9	3.9
Adrenalinum	27	3.8	3.8
Calcitriol Capsules 0.25 Mcg	13	3.8	3.8
Calcitriol Capsules 0.5 Mcg	13	3.8	3.8
Amantadine	10	3.7	3.7
Oral Semaglutide	47	3.7	3.7
Elexacaftor, Tezacaftor, And Ivacaftor	8	3.7	3.7
Nintedanib	20	3.7	3.7
Rivastigmine	12	3.7	3.7
Lanreotide Acetate	5	3.7	3.7
Dorzolamide Hydrochloride And Timolol Maleate	5	3.7	3.7
Niraparib	14	3.7	3.7
Iron Sucrose	6	3.6	3.6
Leucovorin Calcium	12	3.6	3.6
Progesterone	14	3.5	3.5
Palivizumab	9	3.4	3.4
Everolimus	29	3.3	3.3
Glecaprevir And Pibrentasvir	6	3.2	3.2
Abemaciclib	10	2.9	2.9
Cortisone Acetate	6	2.8	2.8
Pazopanib Hydrochloride	12	2.6	2.6
Sunitinib Malate	17	2.5	2.5
Regorafenib	5	2.5	2.5
Cabozantinib	20	2.4	2.4
Axitinib	8	2.4	2.4
Benralizumab	8	2.3	2.3
Rifaximin	8	2.2	2.2
Ranitidine	74	2.2	2.2
Lenvatinib	12	2.1	2.1
Diclofenac Potassium, Film Coated	3	2.1	2.1
Diclofenac Potassium Tablets	3	2.1	2.1
Acetaminophen, Aspirin (Nsaid) And Caffeine	6	2.0	2.0
Naltrexone Hydrochloride And Bupropion Hydrochloride	3	2.0	2.0
Sevelamer Carbonate	4	2.0	2.0
Voclosporin	3	2.0	2.0
Alpelisib	3	2.0	2.0
Vismodegib	3	1.9	1.9
Acetaminophen, Aspirin, And Caffeine	7	1.9	1.9
Liraglutide	16	1.9	1.9
Fam-Trastuzumab Deruxtecan-Nxki	3	1.7	1.7
Romosozumab-Aqqg	4	1.7	1.7
Palbociclib	28	1.7	1.7
Abiraterone	4	1.7	1.7
Exenatide	14	1.5	1.5
Rimegepant Sulfate	3	1.4	1.4
Erenumab-Aooe	13	1.4	1.4
Dimethyl Fumarate	28	1.3	1.3
Osimertinib	7	1.3	1.3
Relugolix	5	1.2	1.2
Vigabatrin	3	1.2	1.2
Tirzepatide	32	1.1	1.1
Pirfenidone	8	1.1	1.1
Ixekizumab	7	1.1	1.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.